Position in NGNE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$349,849
+$130,831 QoQ
Shares Held
11,124
+2.4% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 111 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NGNE Over Time
Shares Held
Position Value (USD)
Derivatives in NGNE
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$230,886
PutShares
10,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. NGNE ranks #261 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in NGNE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $349,849 | 11,124 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $219,018 | 10,864 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $860,234 | 41,759 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $702,782 | 40,553 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $1,426,244 | 95,401 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $615,020 | 52,521 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $230,886 | 10,100 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $605,949 | 26,507 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,702,652 | 40,578 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $984,930 | 27,066 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,042,126 | 20,474 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $963,747 | 49,729 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 NLTX | — | 231,779 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||